Добавил:
kiopkiopkiop18@yandex.ru t.me/Prokururor I Вовсе не секретарь, но почту проверяю Опубликованный материал нарушает ваши авторские права? Сообщите нам.
Вуз: Предмет: Файл:

Ординатура / Хирургия / Библиотека им академика М.И. Перельмана / Книга_3695_Библиотеки_им_академика_М_И_Перельмана

.pdf
Скачиваний:
0
Добавлен:
31.08.2026
Размер:
36 Мб
Скачать
CASE REPORTS IN CARDIOLOGY
https://t.me/medicina_free
Case 1531 Carcinoid Heart Disease Without the Carcinoid Syndrome but with Quadrivalvular Regurgitation and Unsuccessful Operative Intervention
William Clifford Roberts, MD Paul A. Grayburn, MD Burton, MD
a
b,d
a,b,d,
*, Cyril Abie Varughese, DOe, Jong Mi Ko, BAd,
, Robert Frederick Hebeler, Jr., MDc, and Elizabeth C.
A 53-year-old woman is described who underwent mitral and aortic valve replacement and tricuspid valve annuloplasty for pure regurgitation at all 3 valve sites for unrecognized carcinoid heart disease without the carcinoid syndrome 22 days before death. Metastatic carcinoid was not recognized until necropsy, which disclosed a probable ovarian primary but with large hepatic metastases and left-sided cardiac involvement either greater than or equal to the right-sided involvement. Pulmonary hypertension, very unusual in carcinoid heart disease, persisted postoperatively and probably played a role in the patient’s early death. Hepatic metastasis with ovarian primary is most unusual in this circumstance. © 2011 Elsevier Inc. All rights reserved.
(Am J Cardiol 2011;107:788–792)
It was in 1930, 80 years ago, when the rst patient with a metastasizing carcinoid neoplasm associated with brous lesions on the right side of the heart was described.
1
In 1931, the rst patient with metastasizing carcinoid syndrome (head and upper chest ushes and diarrhea) associated with brous lesions not only on the tricuspid and pulmonic valves but also on the anterior mitral leaet and left ventricular mural endocardium was described. reports have appeared describing clinical and morphologic features of the carcinoid syndrome and carcinoid heart disease. in the small intestine, widespread metastases, and specic carcinoid plaques limited to the right side of the heart.
2, 3
The present report was prompted by study of a patient
2, 3
2
Subsequently, of course, numerous
Most patients have the primary carcinoid
with severe mitral and aortic regurgitation leading to double valve replacement but without symptoms of the carcinoid syndrome but with metastasizing carcinoid.
CASE DESCRIPTION
A 53-year-old mother of 6, who was born May5, 1955, and died February18, 2009, had been well until November2008, when she noted exertional dyspnea, subcutaneous peripheral edema, and recurring palpitations, which proved to be runs of atrial brillation. The symptoms gradually worsened, with episodes of rapid heart rate, each lasting several minutes. On January26, 2009, cardiac catheterization disclosed the following pressures in mm Hg: pulmonary arterial wedge mean 22, a wave 30, v wave 28; pulmonary trunk 56/10; right ventricle 56/18; right atrial mean 9, a wave 15, v wave 10; left ventricle 130/26; and aorta 127/58. Left ventriculography
a
Departments of Pathology, bInternal Medicine (Cardiology), and cCardiothoracic Surgery;
d
Baylor Heart and Vascular Institute, Baylor University Medical Center; and eDepartment of Internal Medicine, Methodist Dallas Medical Center, Dallas, Texas, USA. Manuscript received September1, 2010; revised manuscript received and accepted October11, 2010.
*
Corresponding author: Tel: 214-820-7911; fax: 214-820-7533. E-mail address: wc.roberts@baylorhealth.edu (W.C. Roberts).
240 DOI: 10.1201/9781003409281-51
CASE 1531 CARCINOID HEART DISEASE WITHOUT THE CARCINOID SYNDROME
https://t.me/medicina_free
disclosed a normal-sized left ventricular cavity, with an ejection fraction of 60% and 4+/4+ mitral regurgitation. Aortography disclosed 4+/4+ aortic regurgitation. The coronary arteries were angiographically normal. Echocardiography showed thickened mitral and aortic valve cusps and a normal-sized left ventricle (Figure1).
On January27, 2009, the mitral and aortic valves were replaced with mechanical prostheses (#20 ATS Medical [Minneapolis, Minnesota] in the aortic position and #29 St. Jude Medical [St. Paul, Minnesota] in the mitral position). AMaze procedure was also performed as well as tricuspid valve annuloplasty. The operatively excised valves are shown in Figures2 and 3. The 6-day postoperative hospital course was characterized by a weight gain of 6.6 kg (from 76.7 to 83.3 kg), sinus rhythm, and gradual ambulation.
On February 13, 2009, the patient was rehospitalized because of increasing weakness and dyspnea, evidence of gastrointestinal bleeding (on warfarin with an international normalized ratio of 4.7), and large pleural and pericardial effusions. The blood hemoglobin level was 11.1 g/dl, and the hematocrit was 35%. The serum bilirubin level was 1.4 mg/dl; alkaline phosphatase, 295 U/L; aspartate aminotransferase, 210 U/L; and alanine aminotransferase, 147 U/L. The blood urea nitrogen level was 17 mg/dl and glucose 96 mg/dl. The brain natriuretic peptide level was 430 pg/ml (normal range <100). Echocardiography now showed a normal­sized, normally functioning left ventricle, a very dilated and dysfunctional right ventricle, and large pericardial and right pleural effusions (Figure4). Approximately 1,800 ml of serous uid was drained from the right pleural space. Shortly thereafter, the patient had a cardiac arrest and died.
At necropsy, classic carcinoid neoplasms were present in the right ovary (2.3 ×
2.1 × 1.9cm), the liver (2 hemorrhagic and necrotic carcinoid masses, 10 × 9 × 9 and 3 × 3 × 3cm; liver weight 2,100 g); the serosa of the bowel (1 nodule) and uterus (1 nodule); the adrenal glands (multiple small nodules); the pancreas (1 nodule, 0.3cm); and the heart (multiple microscopic-sized nodules). Sections of the tumors in the liver, ovary, and adrenal glands were positive for neuron-specic enolase.
The heart (Figures 5 to 8) weighed 370 g. The coronary arteries were free of atherosclerotic plaque. The left ventricular cavity was small, and the right ventricular cavity was very dilated. No myocardial foci of brosis or necrosis were present,
Figure 1 Preoperative (1 day) echocardiograms in the patient are described. (A) Four-chamber view showing the thickened mitral and tricuspid leaets and the normal-sized right ventricular and left ventricular cavities. (B) Long-axis view again showing the thickened mitral leaets and also a thickened aortic valve cusp. AO=aorta; LA=left atrium; LV=left ventricle; RA=right atrium; RV=right ventricle.
241
CASE REPORTS IN CARDIOLOGY
https://t.me/medicina_free
Figure 2 Photographs of the operatively excised mitral (A,B) and aortic (C,D) valves. (A) View of the atrial aspect of the anterior mitral leaet. (B) View of the ven­tricular aspect of the anterior mitral leaet with marked brous thickening of the chordae tendineae. Afragment of posterior leaet with attached papillary muscle is also visible. (C) Focally thickened ventricular aspect of the tricuspid aortic valve. (D) Aortic aspect.
Figure 3 Photomicrograph of anterior mitral leaet (A), chordae tendineae (B), and aortic valve cusp (C). The underlying leaet and chordae are normal, but both are quite thickened by superimposed cellular brous tissue devoid of elastic brils. The sinus portion of the aortic valve is lled with cellular brous tissue devoid of elastic bers (C). Elastic van Gieson’s stains (100×).
242
CASE 1531 CARCINOID HEART DISEASE WITHOUT THE CARCINOID SYNDROME
https://t.me/medicina_free
Figure 4 Four-chamber echocardiogram shortly before death in the patient described. The right ventricular cavity is severely dilated, whereas the left ventricle (LV) is not dilated. LA=left atrium; RA=right atrium; RV=right ventricle.
Figure 5 X-ray of the heart at necropsy. Prostheses are present in the mitral and aortic valve positions, and a ring is in the tricuspid valve annular position. The left ventricular cavity is not dilated, whereas the right ventricular cavity is considerably dilated.
except in the posteromedial left ventricular papillary muscle, which was brotic. Both atria were dilated, the right more than the left. The pulmonic valve cusps were thickened, and the anterior cusp was rigid and immobile. The foramen ovale was closed.
243
CASE REPORTS IN CARDIOLOGY
https://t.me/medicina_free
Figure 6 View of heart after removing the atrial walls and most of the ascending aorta and pulmonary trunk. The prosthesis in the mitral position lls the entire “oor” of the left atrium. The cloth-covered ring is visible in the tricuspid valve annulus.
COMMENTS
Our patient underwent mitral and aortic valve replacement and tricuspid valve annuloplasty for pure mitral, aortic, and tricuspid valve regurgitation. Examination of the operatively excised valves suggested an appearance similar to that described in patients having taken fenuramine-phentermine for weight reduction. The patient, however, denied having ever taken that medication. Postoperatively, the patient’s condition worsened, and she died 22 days after the operation. Necropsy disclosed carcinoid tumors in 1 ovary, both adrenal glands, the liver, the pancreas, the serosal surfaces of the uterus and bowel, and the heart (intramyocardial). There was never evidence of the carcinoid syndrome (ushing, diarrhea), and the presence of the carcinoid neoplasm was not diagnosed until necropsy, which also disclosed evidence of carcinoid heart disease involving both right-sided cardiac valves as well as both left-sided valves.
The primary in the patient described was not certain, but the ovary appeared to be the most logical site. Only 1 of the 2 ovaries was involved, and the cancerous nodule was >2cm in diameter. Hepatic metastasis of carcinoid with ovarian primary, however, is quite unusual.
4, 5
Chatterjee and Heather6 found hepatic carcinoid metastases in only 1 of 35 reported cases with primary carcinoid in the ovary. Although our patient had only 2 carcinoid metastases in the liver, both were large.
In our patient, carcinoid heart disease involved all 4 cardiac valves: the pulmonic
valve to a worse extent than the aortic valve, but the mitral valve to a worse extent
244
CASE 1531 CARCINOID HEART DISEASE WITHOUT THE CARCINOID SYNDROME
https://t.me/medicina_free
Figure 7 View of various “slices” of the cardiac ventricles showing the very small left ventricular cavity and the very dilated right ventricular cavity.
Figure 8 View of the pulmonic valve from above. The anterior cusp is very thick and immobile. The other 2 cusps are only mildly thickened by brous tissue.
245
CASE REPORTS IN CARDIOLOGY
https://t.me/medicina_free
than the tricuspid valve. Although the pulmonic valve was heavily involved by the carcinoid process, there was no pressure gradient across the valve, although the end-diastolic pressures in both the pulmonary trunk and the right ventricle were similar, indicating pure pulmonic regurgitation.
Is the electrocardiogram helpful in patients with malignant carcinoid in diagnosing carcinoid heart disease? No. Ross and Roberts electrocardiograms in 34 patients with the carcinoid syndrome: the total 12-lead QRS voltages
7
in the 19 patients with carcinoid heart disease ranged from 58 to
3
examined
227mm (mean 105; standardization 10mm) and in the 15 patients without carcinoid heart disease from 89 to 192mm (mean 132). Twelve-lead QRS voltages in 16 men aged 44 to 74years (mean 55) without cardiovascular disease ranged from 84 to 159mm (mean 124) and heart weight from 288 to 392 g (mean 351).
8
Thus, in groups of patients with the carcinoid syndrome, those with carcinoid heart disease have lower total 12-lead QRS voltages, but much overlap occurred between the 2 groups. Our patient had a total 12-lead QRS voltage of 127mm. The duration of the P-R, QRS, and Q-T intervals and heart rates at rest were similar in the 2 groups with and without carcinoid heart disease.
The presence of pulmonary hypertension in our patient is most unusual in carcinoid heart disease and reasonably can be attributed to the left-sided mitral disease.
9
The reason for its persistence postoperatively is unclear. The patient’s symptoms worsened considerably postoperatively. The discs of the prostheses in both mitral and aortic positions moved without interference.
Cardiac valve replacement and/or “repair” for carcinoid heart disease is
becoming more accepted, but nevertheless, outcomes are not always favorable.
9
In an early report from the Mayo Clinic, 9 of 26 patients died in the early perioperative period and 9 others a mean of 19 months postoperatively. Only 4 of their 26 patients had mitral or aortic valve replacement, and none had both valves replaced, as did our patient. Although the mortality was higher, late operative survival (8 of 26 patients) resulted in considerable decrease (2 patients) or elimination (6 patients) of symptoms. patients with carcinoid heart disease who underwent operation for left- and right­sided valve disease:
9
Alater report from the same institution summarized results in 11
10
the tricuspid valve was replaced in all 11, the pulmonic in 3 (valvectomy in 7), the mitral valve in 6 (repair in 1), and the aortic valve in 4 (repair in 2). There were 2 perioperative deaths and 4 additional deaths in a mean follow-up period of 41 months. All but 1 operative survivor improved by >1 functional class. In retrospect, had the presence of carcinoid been recognized preoperatively or at operation in our patient, both tricuspid and pulmonic valves probably also would have been replaced (quadruple valve replacement).
11
ACKNOWLEDGMENT
We thank Brad J. Roberts, BS, RCS, RDCS, for his help in preparing the echocardiogram.
REFERENCES
1. Cassidy MA. Abdominal carcinomatosis with probable adrenal involvement.
Proc Roy Soc Med 1930;24:139 –141.
2. Roberts WC, Sjoerdsma A. The cardiac disease associated with the carcinoid
syndrome (carcinoid heart disease). Am J Med 1964;36:5–34.
3. Ross EM, Roberts WC. The carcinoid syndrome: comparison of 21 necropsy
subjects with carcinoid heart disease to 15 necropsy subjects without carcinoid heart disease. Am J Med 1985;79:339–353.
4. Chaoqalit N, Connolly HM, Schaff HV, Webb MJ, Pellikka PA. Carcinoid
heart disease associated with primary ovarian carcinoid tumor. Am J Cardiol 2004;93:1314–1315.
246
CASE 1531 CARCINOID HEART DISEASE WITHOUT THE CARCINOID SYNDROME
https://t.me/medicina_free
5. Rabban JT, Lerwill MF, McCluggage WG, Grenert JP, Zaloudek CJ. Primary ovar-
ian carcinoid tumors may express CDX-2: a potential pitfall in distinction from metastatic intestinal carcinoid tumors involving the ovary. Int J Gynecol Pathol 2009;28:41–48.
6. Chatterjee K, Heather JC. Carcinoid heart disease from primary ovarian carci-
noid tumors. Am J Med 1968;45:643–648.
7. Siegel RJ, Roberts WC. Electrocardiographic observations in severe aortic valve
stenosis: correlative necropsy study to clinical, hemodynamic, and ECG vari­ables demonstrating relation of 12-lead QRS amplitude to peak systolic transaor­tic pressure gradient. Am Heart J 1982;103:210–221.
8. Odom H II, Davis L, Dinh HA, Baker BJ, Roberts WC, Murphy ML. QRS voltage
measurements in autopsied men free of cardiopulmonary disease: a basis for evaluating total QRS voltage as an index of left ventricular hypertrophy. Am J Cardiol 1986;58:801–804.
9. Connolly HM, Nishimura RA, Smith HC, Pellikka PA, Mullany CJ, Kvols
LK. Outcome of cardiac surgery for carcinoid heart disease. J Am Coll Cardiol 1995;25:410–416.
10. Connolly HM, Schaff HV, Mullany CJ, Rubin J, Abel MD, Pellikka PA. Surgical
management of left-sided carcinoid heart disease. Circulation 2001;104:I36–I40.
11. Arghami A, Connolly HM, Abel MD, Schaff HV. Quadruple valve replacement in
patients with carcinoid heart disease. J Thorac Cardiovasc Surg 2010;140:1432–14 34.
247
CASE REPORTS IN CARDIOLOGY
https://t.me/medicina_free
Case 1559 43.3-Year Durability of a Smeloff­Cutter Ball-Caged Mitral Valve
Stuart J. Head, BS, Jamie Ko, Rajeev Singh, MD, William C. Roberts, MD, and Michael J. Mack, MD
Extended durability of mechanical heart valves has been documented for many years. We describe a case of a ball-caged mechanical valve implanted 43.3years previous to developing valve dysfunction. The patient presented with both prosthetic valve stenosis and insufciency. This Smeloff-Cutter valve (Cutter Laboratories, Berkeley, CA) in the mitral position was dysfunctional due to lipid absorption, which resulted in ball variance and concomitant pannus growth prevented optimal seating of the ball in its cage. This is the longest length of time in which a Smeloff-Cutter mechanical valve has been originally implanted.
(Ann Thorac Surg 2011;91:606–8) © 2011 by The Society of
Thoracic Surgeons
In the early 1960s, heart valves were introduced for hear t valve replacement, which resulted in the rst mechanical valve prosthesis implantation of a Starr-Edwards valve (Edwards Lifesciences, Irvine, CA) in the mitral position in 1961. newly developed ball-caged valves followed in quick succession, manufactured by a number of companies producing aortic and mitral valve prostheses. The Smeloff­Cutter valve (Cutter Laboratories, Berkeley, CA) was introduced in 1964, being the rst “full-ow” valve, which was achieved by including an additional smaller cage on which the ball could rest during valve closure.
2
“Ball variance” is a previously documented cause of valve dysfunction,3 in which lipid absorption in the ball causes it to grow and form surface irregularities, increasing the risk of thromboembolic events and valve dysfunction. We report a case in which ball variance and pannus overgrowth caused a 43.3-year implanted Smeloff-Cutter ball-caged valve to fail. This case is the longest implantation time of this type of valve.
1
After this,
At age 13, mitral valve stenosis developed in the patient, due to rheumatic fever. Therefore, the patient underwent a valve replacement. Recently, the 56-year-old woman presented with New York Heart Association functional class IV symptoms of heart failure and palpitations as a result of long-standing persistent atrial brillation. Transthoracic and transesophageal echocardiography (Figure1) revealed moderate to severe mitral valve regurgitation and severe mitral stenosis with a valve area of
2
and a mean gradient of 15mm Hg. There was decreased left ventricular
0.7 cm function with an ejection fraction of 40%, systemic pulmonary hypertension, and severe tricuspid regurgitation.
Cardiopulmonary Research Science and Technology Institute, Dallas, Texas, Department of Cardio-Thoracic Surgery, Erasmus University Medical Center, Rotterdam, the Netherlands, Department of Pathology, The Baylor Heart and Vascular Institute, Dallas, Department of Cardiology, The Diagnostic Clinic of Longview, Longview, and Heart Hospital Baylor Plano, Plano, Texas
Accepted for publication June29, 2010.
Address correspondence to DrMack, Heart Hospital Baylor Plano, 1100 Allied Dr, Plano, TX 75093; e-mail: mmack@csant.com.
248 DOI: 10.1201/9781003409281-52
CASE 1559 43.3-YEAR DURABILITY OF A SMELOFF-CUTTER BALL-CAGED MITRAL VALVE
https://t.me/medicina_free
Figure 1 Preoperative echocardiogram showing both mitral stenosis and insufciency.
The patient had been noncomplaint with warfarin therapy until suffering a stroke in 1988 after discontinuing therapy, which left her with a signicant residual right hemipharesis. However, this event subsequently made her extremely diligent in taking the anticoagulant with good control and no further clinical events. For this reason, she opted for another mechanical valve.
At the time of the redo mitral valve replacement, a pre-cardiopulmonary bypass transesophageal echocardiographic nding consisted of the mitral valve prosthesis in a good position with severe mitral valve regurgitation. A 2.4 m/s maximum velocity was measured across the valve, calculating to a peak gradient of 23mm Hg and a mean gradient of 9mm Hg. The valve area was 2.3cm and 0.7cm
2
measured by continuity equation. Furthermore, a left ventricular ejection
2
by pressure halftime
fraction of 40% was obtained. All measurements are consistent with preoperative ndings.
The limited access procedure was performed exposing only the aorta and right atrium. Asuperior septal approach to the mitral valve was performed. Inspection of the valve revealed some erosion of the ball (Figure2). Pannus formation built up around the valve prevented the ball to seat completely in its cage. There was an extensive amount of calcium built up both in the annulus and the ventricular muscle below the annulus. The 43.3-year-old valve was replaced with a 25-mm On-X bi-leaet mechanical valve (On-X Life Technologies Inc, Austin, TX). After the valve was implanted, transesophageal echocardiography measured a maximum velocity across the valve of 1.3m/s, with a peak-to-peak gradient of 7mm Hg and a mean gradient of 3mm Hg. By pressure half-time the valve area had improved to 3.5cm
2
. Concomitant tricuspid valve annuloplasty with a 26-mm tricuspid annulus ring and a full left-sided and right-sided Cryo maze procedure were performed. Her postoperative course was uneventful. She was discharged home on postoperative day 6. The patient is in New York Heart Association functional class Iat her most recent follow-up at 6 weeks postoperatively.
COMMENT
Valve dysfunction after extended durability can be the result of a wide variety of causes, including lipid absorption into the ball and pannus formation, causing tissue impingement as the two most common. Absorption increases the
249